Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000
cancer therapeutics

    cancer therapeutics Market Research Reports

    Titlepublishedprice

    Mucositis – Pipeline Review, H1 2014

    By Global Markets Direct
    "......sis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the th......"
    31-Mar-2014$2000

    Polycythemia Vera – Pipeline Review, H1 2014

    By Global Markets Direct
    "...... complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also review......"
    31-Mar-2014$2000

    OpportunityAnalyzer: Pancreatic Cancer – Opportunity Analysis and Forecasts to 2017

    By GlobalData
    "......th the early stage resectable and advanced settings. Celgene's Abraxane was launched in the US and Europe in 2013 and 2014, respectively, and was the first drug approved in this disease in nearly a decade. Due to the high unmet need, GlobalData forec......"
    27-Mar-2014$5995

    NSCLC Therapeutics in Asia-Pacific Markets to 2019 – Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool

    By GBI Research
    "......l Lung Cancer (NSCLC) indication. The report provides an estimation of the market size for 2012 along with market forecasts until 2019 for the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. It also covers disease epidemiology......"
    14-Mar-2014$3500

    Breast Cancer Partnering 2009-2014

    By Current Partnering
    "...... partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors breast cancer technology. These deals tend to be multicomponent, starting with collaborative ......"
    1-Mar-2014$1795

    Lung Cancer Partnering 2009-2014

    By Current Partnering
    "......nering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors lung cancer technology. These deals tend to be multicomponent, starting with collaborative R&D......"
    1-Mar-2014$1795

    Oncology Deals and Alliances of 2013

    By Current Partnering
    "......orts, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report pr......"
    1-Mar-2014$1495

    Therapeutic Class Overview: Treating Refractory Hematological Malignancies

    By MP Advisors
    "......nalidomide) have become the cornerstone of treatment for patients with Multiple Myeloma (MM) resulting in improved survival.  However, eventually all patients relapse and new treatment options for Relapsed/ Refractory Multiple Myeloma (RRMM) are req......"
    22-Feb-2014$2500

    Therapeutic Class Overview: Newer Oral Anti Androgens – Expanding Role in the treatment Paradigm of Prostate Cancer

    By MP Advisors
    "......tellas/Medivation), Zytiga (Abiraterone acetate, JNJ), Jevtana (Cabazitaxel, Sanofi), & Xofigo (radium Ra 223, Boehringer Ingelheim) has evolved the treatment paradigm of treating late stage prostate cancer. In coming years, we expect this to rep......"
    21-Feb-2014$2500

    Rhabdomyosarcoma – Pipeline Review, H2 2013

    By Global Markets Direct
    "...... projects. It also reviews key players involved in the therapeutic development for Rhabdomyosarcoma. Rhabdomyosarcoma Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/U......"
    31-Dec-2013$2000
    Live Chat
    Live Chat by Comm100